PRA International has established operations in New Zealand, adding to the company’s Asia-Pacific operations. PRA can now monitor New Zealand study sites with in-country staff. New Zealand is a research hub for studies in skin cancer, multiple sclerosis, asthma and several other conditions. PRA’s New Zealand staff will work closely with employees in the PRA Sydney, Australia office, allowing for close collaboration for trials simultaneously conducted across Australia and New Zealand. Al...